These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39427335)

  • 1. Identification of novel brain penetrant GSK-3β inhibitors toward Alzheimer's disease therapy by virtual screening, molecular docking, dynamic simulation, and MMPBSA analysis.
    Dasgupta A; Kalidass K; Farisha S; Saha R; Ghosh S; Ampasala DR
    J Biomol Struct Dyn; 2024 Oct; ():1-27. PubMed ID: 39427335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-pharmacophore-based virtual screening to identify GSK-3β inhibitors.
    Natarajan P; Priyadarshini V; Pradhan D; Manne M; Swargam S; Kanipakam H; Bhuma V; Amineni U
    J Recept Signal Transduct Res; 2016 Oct; 36(5):445-58. PubMed ID: 27305963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation.
    Elangovan ND; Dhanabalan AK; Gunasekaran K; Kandimalla R; Sankarganesh D
    J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening of natural compounds and inhibition of a major therapeutic target HsGSK-3β for Alzheimer's disease using computational approaches.
    Shukla R; Singh TR
    J Genet Eng Biotechnol; 2021 May; 19(1):61. PubMed ID: 33945025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational Design of Dual Inhibitors for Alzheimer's Disease: Insights from Computational Screening of BACE1 and GSK-3β.
    Sai Varshini M; Reddy RA; Krishnamurthy PT; Selvaraj D
    Curr Comput Aided Drug Des; 2024; 20(6):998-1012. PubMed ID: 37921183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of natural compounds by virtual screening, molecular docking and dynamics studies and evaluation of their effects on tau level
    Uzunhisarcıklı E; Çelik İ; Yerer MB
    J Biomol Struct Dyn; 2024; 42(1):384-392. PubMed ID: 36946204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of
    Chandel S; Singh R; Gautam A; Ravichandiran V
    J Biomol Struct Dyn; 2022; 40(23):12827-12840. PubMed ID: 34569452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β.
    Kumar A; Srivastava G; Negi AS; Sharma A
    J Biomol Struct Dyn; 2019 Feb; 37(2):275-290. PubMed ID: 29310523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Investigation of Novel Compounds as Dual Inhibitors of AChE and GSK-3β for the Treatment of Alzheimer's Disease.
    Londhe SG; Shenoy M; Kini SG; Walhekar V; Kumar D
    Curr Top Med Chem; 2024; 24(19):1738-1753. PubMed ID: 38859777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors.
    El Kerdawy AM; Osman AA; Zaater MA
    J Mol Model; 2019 May; 25(6):171. PubMed ID: 31129879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying potential Alzheimer's disease therapeutics through GSK-3β inhibition: A molecular docking and dynamics approach.
    Mohammadi Y; Emadi R; Maddahi A; Shirdel S; Morowvat MH
    Comput Biol Chem; 2024 Aug; 111():108095. PubMed ID: 38805865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico screening of glycogen synthase kinase-3β targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer's disease.
    Jabir NR; Shakil S; Tabrez S; Khan MS; Rehman MT; Ahmed BA
    J Biomol Struct Dyn; 2021 Sep; 39(14):5083-5092. PubMed ID: 32588759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An
    Viswanathan S; Sivaraj R; Vasanthi AHR; Subramanian K; Ramesh V
    J Recept Signal Transduct Res; 2024 Aug; ():1-9. PubMed ID: 39188145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological evaluation and energetic analyses of novel GSK-3β inhibitors.
    Zhang D; Liu L; Pang L; Jin Q; Ke K; Hu M; Yang J; Ma W; Xie H; Chen X
    J Cell Biochem; 2018 Apr; 119(4):3510-3518. PubMed ID: 29144001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Bio-evaluation and Molecular Dynamics Simulation of Novel GSK-3β Inhibitors.
    Lyu W; Li Q; Li Q; Chen Y; Wang Y; Tang T; Feng F; Chi H; Li Y; Liu W; Sun H
    Mol Inform; 2021 Dec; 40(12):e2060031. PubMed ID: 34323388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's disease.
    Kumar A; Srivastava G; Srivastava S; Verma S; Negi AS; Sharma A
    J Mol Model; 2017 Aug; 23(8):239. PubMed ID: 28741112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-
    Hartz RA; Ahuja VT; Sivaprakasam P; Xiao H; Krause CM; Clarke WJ; Kish K; Lewis H; Szapiel N; Ravirala R; Mutalik S; Nakmode D; Shah D; Burton CR; Macor JE; Dubowchik GM
    J Med Chem; 2023 Mar; 66(6):4231-4252. PubMed ID: 36950863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Z)-2-(3-Chlorobenzylidene)-3,4-dihydro-N-(2-methoxyethyl)-3-oxo-2H-benzo[b][1,4]oxazine-6-carboxamide as GSK-3β inhibitor: Identification by virtual screening and its validation in enzyme- and cell-based assay.
    Joshi P; Gupta M; Vishwakarma RA; Kumar A; Bharate SB
    Chem Biol Drug Des; 2017 Jun; 89(6):964-971. PubMed ID: 27896926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel harmine derivatives as GSK-3β/DYRK1A dual inhibitors for Alzheimer's disease treatment.
    Qiu J; Feng X; Chen H; Liu W; Liu W; Wu L; Gao X; Liu Y; Huang Y; Gong H; Qi Y; Xu Z; Zhao Q
    Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300404. PubMed ID: 38010470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond Amyloid: A Machine Learning-Driven Approach Reveals Properties of Potent GSK-3β Inhibitors Targeting Neurofibrillary Tangles.
    Nwadiugwu M; Onwuekwe I; Ezeanolue E; Deng H
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.